The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs

Cell Metabolism

Volumn 19, Issue 6, 2014, Pages 1050-1057

  Smith, Eric P ^a   An, Zhibo ^a   Wagner, Constance ^a   Lewis, Alfor G ^a   Cohen, Eric B ^a   Li, Bailing ^a   Mahbod, Parinaz ^a   Sandoval, Darleen ^a   Perez Tilve, Diego ^a   Tamarina, Natalia ^c   Philipson, Louis H ^c   Stoffers, Doris A ^d   Seeley, Randy J ^a   D'Alessio, David A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Medicine Kovler Diabetes Center University of Chicago ^*  (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; INSULIN; RNA; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, MOUSE; GLP1R PROTEIN, MOUSE; GLUCAGON RECEPTOR; GLUCOSE BLOOD LEVEL; TAMOXIFEN; CRE RECOMBINASE; EXENDIN 4; LIRAGLUTIDE; MESSENGER RNA; VILDAGLIPTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; GENE SILENCING; GLUCOSE REGULATION SYSTEM; HYPERGLYCEMIA; INSULIN RELEASE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; KNOCKOUT MOUSE; METABOLISM; SECRETION (PROCESS); DIABETES MELLITUS; DRUG RESPONSE; GLUCOSE ABSORPTION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESPONSE; PANCREAS ISLET CELL FUNCTION; PARACRINE SIGNALING; PLASMA HALF LIFE; PROTEIN EXPRESSION;

ANIMALS; BLOOD GLUCOSE; DIPEPTIDYL PEPTIDASE 4; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLUCOSE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 84902278779     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2014.04.005     Document Type: Article

References (33)

1. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
2. J.G. Barrera, D.A. Sandoval, D.A. D'Alessio, and R.J. Seeley GLP-1 and energy balance: an integrated model of short-term and long-term control Nat. Rev. Endocrinol. 7 2011 507 516
3. J.G. Barrera, K.R. Jones, J.P. Herman, D.A. D'Alessio, S.C. Woods, and R.J. Seeley Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function J. Neurosci. 31 2011 3904 3913
4. M.A. Burmeister, T. Ferre, J.E. Ayala, E.M. King, R.M. Holt, and J.E. Ayala Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice Am. J. Physiol. Endocrinol. Metab. 302 2012 E334 E343
5. J.E. Campbell, and D.J. Drucker Pharmacology, physiology, and mechanisms of incretin hormone action Cell Metab. 17 2013 819 837
6. J.D. Carter, S.B. Dula, K.L. Corbin, R. Wu, and C.S. Nunemaker A practical guide to rodent islet isolation and assessment Biol. Proced. Online 11 2009 3 31
7. D.A. D'Alessio What if gut hormones aren't really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tract Endocrinology 152 2011 2925 2926
8. Y.Z. De Marinis, A. Salehi, C.E. Ward, Q. Zhang, F. Abdulkader, M. Bengtsson, O. Braha, M. Braun, R. Ramracheya, and S. Amisten et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis Cell Metab. 11 2010 543 553
9. C.F. Deacon, M.A. Nauck, M. Toft-Nielsen, L. Pridal, B. Willms, and J.J. Holst Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects Diabetes 44 1995 1126 1131
10. M.Y. Donath, and R. Burcelin GLP-1 effects on islets: hormonal, neuronal, or paracrine? Diabetes Care 36 Suppl 2 2013 S145 S148
11. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
12. H. Ellingsgaard, I. Hauselmann, B. Schuler, A.M. Habib, L.L. Baggio, D.T. Meier, E. Eppler, K. Bouzakri, S. Wueest, and Y.D. Muller et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells Nat. Med. 17 2011 1481 1489
13. S. Feil, N. Valtcheva, and R. Feil Inducible Cre mice Methods Mol. Biol. 530 2009 343 363
14. D. Flamez, A. Van Breusegem, L.A. Scrocchi, E. Quartier, D. Pipeleers, D.J. Drucker, and F. Schuit Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene Diabetes 47 1998 646 652
15. L. Hansen, C.F. Deacon, C. Orskov, and J.J. Holst Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine Endocrinology 140 1999 5356 5363
16. J.J. Holst, and C.F. Deacon Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors Diabetologia 48 2005 612 615
17. G.G. Holz 4th, W.M. Kühtreiber, and J.F. Habener Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37) Nature 361 1993 362 365
18. S. Jayaraman Assessment of beta cell viability Curr. Protoc. Cytom. Chapter 6 2011 Unit 6.27
19. L. Jessen, B.A. Aulinger, J.L. Hassel, K.J. Roy, E.P. Smith, T.M. Greer, S.C. Woods, R.J. Seeley, and D.A. D'Alessio Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4 Endocrinology 153 2012 5735 5745
20. K.A. Kaihara, L.M. Dickson, D.A. Jacobson, N. Tamarina, M.W. Roe, L.H. Philipson, and B. Wicksteed β-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion Diabetes 62 2013 1527 1536
21. T.J. Kieffer, and J.F. Habener The glucagon-like peptides Endocr. Rev. 20 1999 876 913
22. G. Kilimnik, A. Kim, D.F. Steiner, T.C. Friedman, and M. Hara Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration Islets 2 2010 149 155
23. B.J. Lamont, Y. Li, E. Kwan, T.J. Brown, H. Gaisano, and D.J. Drucker Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice J. Clin. Invest. 122 2012 388 402
24. Y. Nie, M. Nakashima, P.L. Brubaker, Q.L. Li, R. Perfetti, E. Jansen, Y. Zambre, D. Pipeleers, and T.C. Friedman Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats J. Clin. Invest. 105 2000 955 965
25. E.B. Rüttimann, M. Arnold, J.J. Hillebrand, N. Geary, and W. Langhans Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms Endocrinology 150 2009 1174 1181
26. M. Salehi, B. Aulinger, R.L. Prigeon, and D.A. D'Alessio Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes Diabetes 59 2010 1330 1337
27. D.A. Sandoval, D. Bagnol, S.C. Woods, D.A. D'Alessio, and R.J. Seeley Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake Diabetes 57 2008 2046 2054
28. J. Schirra, K. Sturm, P. Leicht, R. Arnold, B. Göke, and M. Katschinski Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans J. Clin. Invest. 101 1998 1421 1430
29. B. Thorens Brain glucose sensing and neural regulation of insulin and glucagon secretion Diabetes Obes. Metab. 13 Suppl 1 2011 82 88
30. T.P. Vahl, M. Tauchi, T.S. Durler, E.E. Elfers, T.M. Fernandes, R.D. Bitner, K.S. Ellis, S.C. Woods, R.J. Seeley, J.P. Herman, and D.A. D'Alessio Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats Endocrinology 148 2007 4965 4973
31. T. Vilsbøll, T. Krarup, J. Sonne, S. Madsbad, A. Vølund, A.G. Juul, and J.J. Holst Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus J. Clin. Endocrinol. Metab. 88 2003 2706 2713
32. A. Waget, C. Cabou, M. Masseboeuf, P. Cattan, M. Armanet, M. Karaca, J. Castel, C. Garret, G. Payros, and A. Maida et al. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice Endocrinology 152 2011 3018 3029
33. B. Wicksteed, M. Brissova, W. Yan, D.M. Opland, J.L. Plank, R.B. Reinert, L.M. Dickson, N.A. Tamarina, L.H. Philipson, and A. Shostak et al. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain Diabetes 59 2010 3090 3098